Market closed
Tandem Diabetes Care/$TNDM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tandem Diabetes Care
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Ticker
$TNDM
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
2,650
ISIN
US8753722037
Website
TNDM Metrics
BasicAdvanced
$1.5B
-
-$2.80
1.53
-
Price and volume
Market cap
$1.5B
Beta
1.53
52-week high
$53.69
52-week low
$15.75
Average daily volume
1.7M
Financial strength
Current ratio
2.302
Quick ratio
1.718
Long term debt to equity
278.027
Total debt to equity
317.597
Interest coverage (TTM)
-12.46%
Management effectiveness
Return on assets (TTM)
-6.17%
Return on equity (TTM)
-92.31%
Valuation
Price to revenue (TTM)
1.52
Price to book
9.75
Price to tangible book (TTM)
9.75
Price to free cash flow (TTM)
-393.705
Growth
Revenue change (TTM)
27.65%
Earnings per share change (TTM)
28.88%
3-year revenue growth (CAGR)
10.04%
3-year earnings per share growth (CAGR)
215.35%
What the Analysts think about TNDM
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Tandem Diabetes Care stock.
TNDM Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
TNDM Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
TNDM News
AllArticlesVideos
Tandem Diabetes Care, Inc. (TNDM) Q1 2025 Earnings Conference Call Transcript
Seeking Alpha·1 week ago
Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025
Business Wire·1 month ago
Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism
Seeking Alpha·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tandem Diabetes Care stock?
Tandem Diabetes Care (TNDM) has a market cap of $1.5B as of May 10, 2025.
What is the P/E ratio for Tandem Diabetes Care stock?
The price to earnings (P/E) ratio for Tandem Diabetes Care (TNDM) stock is 0 as of May 10, 2025.
Does Tandem Diabetes Care stock pay dividends?
No, Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders as of May 10, 2025.
When is the next Tandem Diabetes Care dividend payment date?
Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders.
What is the beta indicator for Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.